Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

5Am Ventures Iii, L.p.


  • Large Shareholder at Arvinas Inc. (ARVN), 2019-09-19
  • Other at Audentes Therapeutics Inc. (BOLD), 2017-04-27
  • Large Shareholder at Cidara Therapeutics Inc. (CDTX), 2015-04-22
  • Large Shareholder at Epirus Biopharmaceuticals Inc. (EPRS), 2015-02-06
  • Large Shareholder at Relypsa Inc (RLYP), 2014-12-11
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
ARVN $22.02 9,045 Large Shareholder 91,162 2019-06-28 Filing
ARVN $22.02 350,955 Large Shareholder 3,537,261 2019-06-28 Filing
ARVN $21.75 11,306 Large Shareholder 100,207 2019-06-27 Filing
ARVN $21.75 438,694 Large Shareholder 3,888,216 2019-06-27 Filing
ARVN $19.65 4,774 Large Shareholder 111,513 2019-06-07 Filing